These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1674853)

  • 1. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls.
    Lesch KP; Hoh A; Disselkamp-Tietze J; Wiesmann M; Osterheider M; Schulte HM
    Arch Gen Psychiatry; 1991 Jun; 48(6):540-7. PubMed ID: 1674853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.
    Lesch KP; Hoh A; Schulte HM; Osterheider M; Müller T
    Psychopharmacology (Berl); 1991; 105(3):415-20. PubMed ID: 1686817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A receptor-effector system responsivity in panic disorder.
    Lesch KP; Wiesmann M; Hoh A; Müller T; Disselkamp-Tietze J; Osterheider M; Schulte HM
    Psychopharmacology (Berl); 1992; 106(1):111-7. PubMed ID: 1346719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression.
    Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Schoellnhammer G; Schulte HM
    Life Sci; 1990; 46(18):1271-7. PubMed ID: 1971701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
    Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
    Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E; DeCaria CM; Nitescu A; Gully R; Suckow RF; Cooper TB; Gorman JM; Klein DF; Liebowitz MR
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.
    Cleare AJ; Forsling M; Bond AJ
    Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
    Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC; Goodman WK; Price LH
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():79-82. PubMed ID: 8201248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
    Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
    J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.
    Lesch KP; Mayer S; Disselkamp-Tietze J; Hoh A; Wiesmann M; Osterheider M; Schulte HM
    Biol Psychiatry; 1990 Oct; 28(7):620-8. PubMed ID: 1977479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls.
    Hollander E; DeCaria C; Nitescu A; Cooper T; Stover B; Gully R; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 May; 37(2):161-77. PubMed ID: 1876628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A receptor responsivity in anxiety disorders and depression.
    Lesch KP
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):723-33. PubMed ID: 1763190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.